RecallRadar

FDA Drug recall D-1361-2020

Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough suppressant), guaifenesin (expectorant), 4 FL OZ. bottle…

On 2020-07-08 the FDA classified a Class II recall of Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough suppressant), guaifenesin (expectorant), 4 FL OZ. bottle… by Glaxosmithkline Consumer Healthcare Holdings, citing defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1361-2020
ClassificationClass II
Statusterminated
Initiated2020-06-16
Published2020-07-08
Last updated2026-09-13 11:52 UTC
CompanyGlaxosmithkline Consumer Healthcare Holdings
DistributionUS

Product

Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough suppressant), guaifenesin (expectorant), 4 FL OZ. bottle (118 mL), Distributed by: Pfizer, Madison, NJ 07940 USA, UPC: 50300318760128, NDC: 0031-8760-12.

Reason

Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.

Identifiers

upc50300318760128
ndc0031-8760-12
ndc5030031876
code_infoLot #s: 02177, 02178, Exp. 01/31/2022

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1361-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.